David Butler

Assistant Professor

Albany College of Pharmacy and Health Sciences

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Butler is an Assistant Professor at Albany College of Pharmacy and Health Sciences in the United States. His research primarily focuses on pharmacokinetics and pharmacodynamics, particularly concerning antibiotic optimization and combination therapies for Gram-negative infections. Recent publications include reviews and studies on the efficacy of aminoglycosides and the implications of continuous renal replacement therapy on antibiotic dosing strategies.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Eric Wenzler

UNITED STATES

View details

Zackery Bulman

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Butler

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature

Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration

Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy (vol 61, pg 539, 2022)

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy

Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib

Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6 ')-Ib

Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data.

Reply to Baud and Houzé, "Should In Vitro and In Vivo Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?"

Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data

Collaborators (2)

Eric Wenzler

Zackery Bulman

Make your next move.